Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Patrick Yung Chih Wen, M.D.

Co-Author

This page shows the publications co-authored by Patrick Wen and Peter Black.
Connection Strength

0.907
  1. Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res. 2009 Jan 01; 15(1):330-7.
    View in: PubMed
    Score: 0.102
  2. A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):222-7.
    View in: PubMed
    Score: 0.098
  3. Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults. Neuro Oncol. 2008 Jun; 10(3):300-8.
    View in: PubMed
    Score: 0.097
  4. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro Oncol. 2007 Jul; 9(3):354-63.
    View in: PubMed
    Score: 0.091
  5. Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery. 1998 Mar; 42(3):446-53; discussion 453-4.
    View in: PubMed
    Score: 0.048
  6. A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas. Clin Cancer Res. 1997 Mar; 3(3):381-7.
    View in: PubMed
    Score: 0.045
  7. High-grade astrocytomas. Neurol Clin. 1995 Nov; 13(4):875-900.
    View in: PubMed
    Score: 0.041
  8. Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas. Cancer. 1994 Jun 15; 73(12):3029-36.
    View in: PubMed
    Score: 0.037
  9. Complications of therapy for venous thromboembolic disease in patients with brain tumors. Neurology. 1993 Jun; 43(6):1111-4.
    View in: PubMed
    Score: 0.035
  10. Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol. 1992 Sep; 10(9):1379-85.
    View in: PubMed
    Score: 0.033
  11. Outcomes after discontinuation of antiepileptic drugs after surgery in patients with low grade brain tumors and meningiomas. J Neurooncol. 2012 May; 107(3):565-70.
    View in: PubMed
    Score: 0.031
  12. Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys. 1990 Dec; 19(6):1455-62.
    View in: PubMed
    Score: 0.029
  13. Morphological characteristics of brain tumors causing seizures. Arch Neurol. 2010 Mar; 67(3):336-42.
    View in: PubMed
    Score: 0.028
  14. DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor. J Clin Oncol. 2008 Oct 10; 26(29):4843-4.
    View in: PubMed
    Score: 0.025
  15. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. J Natl Cancer Inst. 2007 Apr 18; 99(8):639-52.
    View in: PubMed
    Score: 0.023
  16. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res. 2006 Dec 01; 66(23):11502-13.
    View in: PubMed
    Score: 0.022
  17. Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones. J Neuropathol Exp Neurol. 2000 Dec; 59(12):1044-50.
    View in: PubMed
    Score: 0.015
  18. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol. 2000 Feb; 18(4):708-15.
    View in: PubMed
    Score: 0.014
  19. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999 Jan; 90(1):72-7.
    View in: PubMed
    Score: 0.013
  20. 5-[125I]iodo-2'-deoxyuridine in the radiotherapy of brain tumors in rats. J Nucl Med. 1998 Jul; 39(7):1148-54.
    View in: PubMed
    Score: 0.012
  21. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Int J Radiat Oncol Biol Phys. 1998 Jan 01; 40(1):65-70.
    View in: PubMed
    Score: 0.012
  22. Intrathecal 5-[125I]iodo-2'-deoxyuridine in a rat model of leptomeningeal metastases. J Nucl Med. 1997 Mar; 38(3):386-90.
    View in: PubMed
    Score: 0.011
  23. Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor. J Nucl Med. 1996 Apr; 37(4 Suppl):19S-22S.
    View in: PubMed
    Score: 0.011
  24. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery. 1995 Feb; 36(2):275-82; discussion 282-4.
    View in: PubMed
    Score: 0.010
  25. Stereotactic radiosurgery for the definitive, noninvasive treatment of brain metastases. J Natl Cancer Inst. 1995 Jan 04; 87(1):34-40.
    View in: PubMed
    Score: 0.010
  26. A phase I study of etanidazole and radiotherapy in malignant glioma. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):617-20.
    View in: PubMed
    Score: 0.009
  27. Specific uptake of the auger electron-emitting thymidine analogue 5-[123I/125I]iodo-2'-deoxyuridine in rat brain tumors: diagnostic and therapeutic implications in humans. Cancer Res. 1990 Aug 15; 50(16):5199-203.
    View in: PubMed
    Score: 0.007
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.